Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Transplantation Proceedings

• Publication date

  1996-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 8623210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506.

  1995cited by this paper
• Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.

  1995cited by this paper
• Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.

  1995cited by this paper
• Comparison of Different Assays for the Quantitation of FK 506 Levels in Blood or Plasma

  1994cited by this paper
• Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506.

  1994cited by this paper
• THE EFFECT OF FK506 VERSUS CYCLOSPORINE ON GLUCOSE AND LIPID METABOLISM—A RANDOMIZED TRIAL

  1994cited by this paper
• Metabolic Effects of Cyclosporin A and FK 506 in Liver Transplant Recipients

  1993cited by this paper
• New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.

  1991cited by this paper
• Current status of FK 506 in liver transplantation.

  1991cited by this paper
• Oral glucose tolerance test in liver recipients treated with FK 506.

  1990cited by this paper
• Effects of cyclosporine therapy on plasma lipoprotein levels.

  1989cited by this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cited by this paper

• Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial.

  2004cites this paper
• Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

  2000cites this paper
• Pathophysiology and treatment of lipid perturbation after cardiac transplantation.

  1997cites this paper